UnknownPhase 1

Detection of Functioning Pituitary Microadenoma: PET/MRI Versus PET/CT

China100 participantsStarted 2013-02

Plain-language summary

This is a prospective case-control study to compare the usefulness of 18F-FDG PET/MRI with that of 18F-FDG PET/CT in detection of functioning pituitary microadenomas.A single dose of 370 Mega-Becquerel (MBq) 18F-FDG will be injected intravenously.Visual and semiquantitative method will be used to assess the PET/MRI and PET/CT images.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who were pathologically diagnosed with pituitary adenoma after surgery were recruited, and were able to provide basic information and sign the written informed consent form. Exclusion Criteria: * The exclusion criteria included claustrophobia, kidney or liver failure, and inability to fulfill the study.

What they're measuring

Standardized uptake value of 18F-FDG in pituitary adenoma

Timeframe: 5 years

Trial details

NCT IDNCT03404414

SponsorPeking Union Medical College Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11

Contact for this trial

Hao Wang, PhD

+86 10 69154196 474556259@qq.com

View on ClinicalTrials.gov More Pituitary Adenoma trials